Prevalence and characteristics associated with use of hormone replacement therapy in britain

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 104, Issue 3, 1997, Pages 290-297

  Moorhead, Timothy ^a   Hannaford, Philip ^a   Warskyj, Maria ^a  

^a ROYAL COLLEGE OF GENERAL PRACTITIONERS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AGE; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; UNITED KINGDOM;

ADULT; ESTROGEN REPLACEMENT THERAPY; FEMALE; GREAT BRITAIN; HUMANS; HYSTERECTOMY; MENOPAUSE; MIDDLE AGED; ODDS RATIO; PATIENT ACCEPTANCE OF HEALTH CARE; SMOKING; TIME FACTORS;

EID: 0031048810     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1997.tb11456.x     Document Type: Article

References (31)

1. Barret-Connor, E. Postmenopausal estrogen and prevention bias. Ann Intern Med 1991; 115: 455–456.
2. Meade TW, Berra A. Hormone replacement therapy and cardiovascular disease. Br Med Bull 1992; 48: 276–308.
3. Vandenbroucke JP. How much of the cardioprotective effect of post-menopausal estrogens is real Epidemiology 1995; 6: 207–208.
4. Hunt K, Vessey M, McPherson K, Coleman M. Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynaecol 1987; 94: 620–635.
5. Coope J, Roberts D. A clinic for the prevention of osteoporosis in general practice. Br J Gen Pract 1990; 40: 295–299.
6. Kadri, AF. Hormone replacement therapy—a survey of peri-menopausal women in a community setting. Br J Gen Pract 1991; 41: 109–112.
7. Isaacs AJ, Britton AR, McPherson K. Utilisation of hormone replacement therapy by women doctors. BMJ 1995; 311: 1399–1401.
8. Royal College of General Practitioners. Oral Contraceptives and Health. London : Pitman Medical, 1974.
9. Vessey M, Villard-Mackintosh L, et al. The epidemiology of hysterectomy: Findings in a large cohort study. Br J Obstet Gynaecol 1992; 99: 402–407.
10. Coulter A, McPherson K, Vessey M. Do British women undergo too many or too few hysterectomies Soc Sci Med 1988; 27: 987–994.
11. Epidemiological Graphics, Estimation and Testing (EGRET) [computer program]. Seattle, Washington : Statistics and Epidemiology Research Corporation.
12. Greenberg G, Thompson SO, Meade TW. Relation between cigarette smoking and use of hormonal replacement therapy for menopausal symptoms. J Epidemiol Commun Health 1987; 41: 26–29.
13. Sinclair HK, Bond CM, Taylor RJ. Hormone replacement therapy: A study of women's knowledge and attitudes. Br J Gen Pract 1993; 43: 365–370.
14. Spector TD. Use of oestrogen replacement therapy in high risk groups in the United Kingdom. BMJ 1989; 299: 1434–1435.
15. Wilkes HC, Meade TW. Hormone replacement therapy in general practice: A survey of doctors in the MRCs general practice research framework. BMJ 1991; 302: 1317–1320.
16. Stampfer MJ, Willett WC, Colditz GA et al. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 1985; 313: 1044–1049.
17. Køster A. Hormone replacement therapy: Use patterns in 51 year old Danish women. Maturitas 1990; 345–356.
18. Hemminki E, Malin M, Topo P. Selection to postmenopausal therapy by women's characteristics. J Clin Epidemiol 1993; 46: 211–219.
19. Lancaster T, Surman G, Lawrence M et al. Hormone replacement therapy: Characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records. J Epidemiol Commun Health 1995; 49: 389–394.
20. Griffiths F, Jones K. The use of hormone replacement therapy; results of a community survey. FamPract 1995; 12: 163–165.
21. Stadel BV, Weiss N. Characteristics of menopausal women: A survey of King and Pierce Counties in Washington, 1973–1974. Am J Epidemiol 1975; 102: 209–216.
22. Cauley JA, Cummings SR, Black DM et al. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 1990; 163: 1438–1444.
23. Wilson PWF, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking and cardiovascular morbidity in women over 50—The Framingham Study. N Engl J Med 1985; 313: 1038–1043.
24. Barrett-Connor E, Wingard DL, Criqui MH. Postmenopausal estrogen use and heart disease risk factors in the 1980's. JAMA 1989; 261: 2095–2100.
25. Bryce FC, Lilford RJ. General practitioners' use of hormone replacement therapy in Yorkshire. Eur J Obstet Gynecol Reprod Biol 1990; 37: 55–61.
26. Norman SG, Studd JWW. A survey of views on hormone replacement therapy. Br J Obstet Gynaecol 1994; 101: 879–887.
27. Vessey MP. The Jephcott Lecture 1989: An overview of the benefits and risks of combined oral contraceptives. In: Mann RD, editor. Oral Contraceptives and Breast Cancer. Carnforth : Parthenon Publishing Group Ltd, 1990: 121–135.
28. British Medical Association/Royal Pharmaceutical Society of Great Britain. British National Formulary. No. 29. London : British Medical Association/The Pharmaceutical Press, 1995.
29. Grady D, Rubin SM, Petitti DB et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016–1037.
30. Beral V, Hermon C, Kay C et al. Mortality in relation to method of follow-up in the Royal College of General Practitioners' Oral Contraception Study. In: Hannaford PC, Webb A, editors. Evidence-Guided Prescribing of the Pill. Carnforth : Parthenon Publishing Group Ltd, 1996: 327–339.
31. Office of Population Censuses and Surveys. General Household Survey: Cigarette Smoking 1972 to 1990. SS 9 1/3. London : Opcs, 1991.